CRSP
#1274
CRISPR Therapeutics AG - Common Shares
56.9 1 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.12%
Changement Mensuel
+18.46%
Evolution sur 6 mois
-1.95%
Changement Annuel
+11.59%
Clôture Précédente
56.9 8
Open
56.6 4
Low
56.3 5
High
56.9 1
Volume
166
Financials
- Market Capitalization 5.5 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-11.58
ratio cours/chiffre d'affaires
389.54
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1235 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.90 USD | -0.53% | -1.24% | -5.24% | +46.85% | 5.80 B USD | ||
| 1255 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 283.55 USD | -0.19% | +0.49% | -1.25% | +51.53% | 5.65 B USD | ||
| 1303 |  DFTX Definium Therapeutics, Inc. - Common Shares | 39.16 USD | -1.41% | -13.21% | -8.65% | +159.17% | 5.26 B USD | ||
| 1341 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 28.91 USD | 0.00% | -4.71% | +11.32% | +11.58% | 4.98 B USD |